Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
Publication Type:
Journal Article
Authors:
van der Meer, A.J.;
Veldt, B.J.;
J J Feld;
Wedemeyer, H.;
Dufour, J.F.;
Lammert, F.;
Duarte-Rojo, A.;
Heathcote, E.J.;
Manns, M.P.;
Kuske, L.;
Stefan Zeuzem;
Hofmann, W.P.;
de Knegt, R.J.;
Hansen, B.E.;
H L JanssenSource:
JAMA, Volume 308, Issue 24, p.2584-2593 (2012)
Keywords:
Adult,
analysis,
Antiviral Agents,
Canada,
Carcinoma,
Cause of Death,
chronic HCV,
complications,
CONTEXT,
Death,
drug therapy,
epidemiology,
Europe,
Female,
Fibrosis,
Follow-Up Studies,
HCV,
hepatitis,
Hepatitis C,
hepatitis C virus,
Hepatitis C,Chronic,
Hospitals,
Humans,
Incidence,
Infection,
interferon,
Interferons,
Liver,
Liver Cirrhosis,
Liver Failure,
Liver Transplantation,
Male,
Middle Aged,
Mortality,
Multicenter Studies,
Netherlands,
Patients,
Regression Analysis,
Research,
Research Support,
Risk,
secondary,
SVR,
therapeutic use,
transplantation,
Viremia,
virology
